More Weakness

While the market is showing increased fear and weakness, we are still within the parameters for a double bottom, so do not discount it just yet. GENE is back on the radar, but I am hesitant in rebuying after the halting nonsense. I suppose, if you wanted to day trade it, you can while avoiding the carry over risk of the halt.

Showing Strength: ADRL, AERL, GENE, TSTF

Breaking Down: AGP, BORN, CYH, CYOU, DHX, ENSG, HAE, HCA, HGR, HRC, KND, LIWA, OCR, OHI, SBRA, SKH, UHS, VHS

Short Watch: All healthcare plan stocks are being pummeled. These will lead to deep corrections industry wide, leading to strong shorting opportunities.